Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice

BACKGROUND: (211)At is one of the ideal nuclides for targeted radionuclide therapies (TRTs). Meta-[(211)At]astatobenzylguanidine ((211)At-MABG) has been proposed for the treatment of pheochromocytoma. To effectively use these radiopharmaceuticals, dosimetry must be performed. It is important to dete...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Phys
Main Authors: Ukon, Naoyuki, Zhao, Songji, Washiyama, Kohshin, Oriuchi, Noboru, Tan, Chengbo, Shimoyama, Saki, Aoki, Miho, Kubo, Hitoshi, Takahashi, Kazuhiro, Ito, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509022/
https://ncbi.nlm.nih.gov/pubmed/32960387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-020-00326-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados